Collyer Medical Limited 11687423 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of provision of general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 11687423 2024-04-01 2025-03-31 11687423 2025-03-31 11687423 core:RetainedEarningsAccumulatedLosses 2025-03-31 11687423 core:ShareCapital 2025-03-31 11687423 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 11687423 bus:SmallEntities 2024-04-01 2025-03-31 11687423 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 11687423 bus:FullAccounts 2024-04-01 2025-03-31 11687423 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11687423 bus:RegisteredOffice 2024-04-01 2025-03-31 11687423 bus:Director2 2024-04-01 2025-03-31 11687423 bus:Director2 1 2024-04-01 2025-03-31 11687423 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11687423 countries:EnglandWales 2024-04-01 2025-03-31 11687423 2023-04-01 2024-03-31 11687423 2024-03-31 11687423 core:RetainedEarningsAccumulatedLosses 2024-03-31 11687423 core:ShareCapital 2024-03-31 11687423 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 11687423

Collyer Medical Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

Collyer Medical Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Collyer Medical Limited

(Registration number: 11687423)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Current assets

 

Debtors

21,268

4,731

Cash at bank and in hand

 

-

16,269

 

21,268

21,000

Creditors: Amounts falling due within one year

(6,033)

(7,778)

Net assets

 

15,235

13,222

Capital and reserves

 

Called up share capital

200

200

Profit and loss account

15,035

13,022

Total equity

 

15,235

13,222

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the Company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 6 December 2025 and signed on its behalf by:
 

Mr D Collyer

Director

 

Collyer Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
West View
Bridge Street
Ledbury
Herefordshire
HR8 2AN

These financial statements were authorised for issue by the Board on 6 December 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable the future economic benefits will flow into the entity, and specific criteria have been met for each of the company activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

 

Collyer Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

4

Related party transactions

Advances to directors


Mr D Collyer

During the period Mr D Collyer went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £33,860 (2024 - £4,731). At the year end the amount outstanding from Mr D Collyer was £21,269. Interest has been charged at the approved HMRC interest rate.